About FoxHollow Technologies
FoxHollow Technologies is a company based in Redwood City (United States) founded in 1996 was acquired by ev3 Endovascular in July 2007. FoxHollow Technologies has raised $17.72 million across 2 funding rounds from investors including ev3 Endovascular and De Novo Ventures. FoxHollow Technologies operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Redwood City, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Foxhollow Technologies Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.72 M (USD)
in 2 rounds
-
Latest Funding Round
$11.72 M (USD), Series B
Sep 01, 2006
-
Investors
ev3 Endovascular
& 1 more
-
Employee Count
Not available
-
Acquired by
ev3 Endovascular
(Jul 22, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of FoxHollow Technologies
Unlock access to complete
Funding Insights of FoxHollow Technologies
FoxHollow Technologies has successfully raised a total of $17.72M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.72 million completed in September 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in FoxHollow Technologies
FoxHollow Technologies has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ev3 Endovascular and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Surgical products for treatment of Peripheral vascular & Neurovascular diseases
|
Locked | Locked | Locked |
Investor details for FoxHollow Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FoxHollow Technologies
Investment portfolio details for FoxHollow Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FoxHollow Technologies
Detailed financials for FoxHollow Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Foxhollow Technologies Comparisons
Peer comparison for FoxHollow Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FoxHollow Technologies
FoxHollow Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for treating peripheral and coronary vascular disease are developed.
|
|
| Locked | Locked | Locked |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| Locked | Locked | Locked |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| Locked | Locked | Locked |
Smart devices for monitoring coronary artery disease are developed.
|
|
| Locked | Locked | Locked |
Embolization devices are developed using Shape Memory Polymer foams.
|
|
| Locked | Locked | Locked |
Developer a system for venous arterialization of the lower limbs
|
Detailed competitors of FoxHollow Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Foxhollow Technologies
Complete news archive for FoxHollow Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FoxHollow Technologies
FoxHollow Technologies was founded in 1996 and raised its 1st funding round 7 years after it was founded.
FoxHollow Technologies is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
FoxHollow Technologies is a funded company, having raised a total of $17.72M across 2 funding rounds to date.
FoxHollow Technologies, formerly known as ArteRx, develops medical devices for the treatment of coronary and peripheral arterial disease. Its flagship product SilverHawk Plaque Excision System is a minimally invasive catheter system that enables plaque removal to unblock arteries. Another product Rinspirator removes clots from blocked arteries. In July 2007, it was acquired by ev3 for 780M.
FoxHollow Technologies's top competitors include Contego Medical, Limflow and Shape Memory Medical.
FoxHollow Technologies has 2 investors. Key investors include ev3 Endovascular, and De Novo Ventures.